B2BROKER
17.2.2020 11:02:04 CET | Business Wire | Press release
B2Broker , a leading liquidity and technology provider of solutions to the forex and crypto industry, is pleased to introduce B2Core , a major upgrade to its client cabinet solution Trader’s Room, which has undergone a major overhaul in response to client demand and to meet today’s exacting business needs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200217005010/en/
All New Client Cabinet Concept
B2Core takes on a whole new guise embracing a vast new range of new capabilities, culminating in an innovative and unique bespoke service for clients. B2Core offers an all-round, greatly improved user experience compared with the company’s previous version. It consolidates all previous aspects of Traders room, including clients area, etc, elevating the company’s existing SaaS solution to the top of its league in the financial services industry.
Businesses looking for a solution with functionality that can handle a broader and more customised range of demands than the industry-standard traders room solution will find B2Core exceeds their expectations and outperforms other products in the market with a range of advanced features that can be tailored to fit each type of organisation. With B2Core, businesses no longer need to accept a one-size-fits-all solution.
Unique Pack-Based Solution
From basic tasks such as organising the work of forex brokers and crypto exchanges, back office for employees and administrators, front-end for traders, verification and registration of customers and a huge range of payment functions, B2Core brings to the market a whole new concept of a pack-based solution.
This essentially means that B2Core clients can now choose a package that suits their requirements best. For example, the B2Core Standard pack includes a basic set of features and offers a budget-friendly solution. Alternatively, businesses can opt for an Advanced pack with many more potential features and modules such as bonuses, IB Room and Converter, and integrations with a large choice of payment solutions and external platforms such as B2Trader, MetaTrader, CTrader, dxTrade, AlphaPoint, OneZero and PrimeXM.
At the top end of the scale for larger corporates, B2Core offers an Enterprise pack, a solution which is ideal for where the client has their own specific requirements and demands regarding the type of solution they want. In this respect, B2Broker develops and maintains the solution accordingly.
The newly adapted B2Core pack-based solution means that B2Broker can offer a product which is more responsive to its clients requirements and more flexible in that the solution can be adjusted to meet a wide range of needs.
B2Core is a must-have choice for any professional business including FX and crypto brokers, converters, spot and margin exchanges, EMIs and crypto wallets, adding an extra dimension to the existing Trader’s Room offering with the following all-important features:
Dynamic Advanced UI Layout
The first of the new features is an ideal opportunity for all Exchange clients to obtain one of the most advanced front-end layouts on the market. The end-user of the Exchange will be able to fully customize the workspaces in order to maximize the efficiency of their trading performance and combine it with the satisfaction of usage.
For example, users can now organize the blocks of order books, watchlist, charts, history of trades, change the size and order of these windows without any limitations to get the best usability and maximum customization of the platform. It is also possible to create several workspaces to enable users to have separate areas for different trading purposes.
Another new feature is Market Depth which shows the market's ability to sustain relatively large market orders without impacting on the price of the asset in question. Market depth takes into consideration the overall level and breadth of current open orders within an individual currency pair.
Grouping of volumes is a significant part of the update which allows users to analyze the deepest liquidity available on the platform. It can be accessed in the order book of every instrument.
Finally, the Watchlist widget can now be added to the workspaces of the Trading UI. Users are able to make a list of the pairs that they wish to monitor and display the current prices, volumes and 24 hour highs & lows in one place.
Overall, the Trading UI is now capable of fulfilling all the demands of professional traders who frequently use it to monitor large amounts of information.
Advanced Anti-Fraud Homemade System
B2Core’s Advanced Anti-Fraud Homemade System is an automatic withdrawals system featuring security alerts and other procedures to avoid money-laundering and trading cheating procedures on the platform.
Sum-Sub WebSDK Integration
Sum-Sub WebSDK integration provides advanced and highly customizable Know Your Customer (KYC) procedures that will enable a business owner to avoid legal department costs as everything is handled automatically by the technology provider.
PrimeXM/OneZero Integration
As well as deep integration with the industry’s flagship trading platform MetaTrader 4 and 5, B2Core is now integrated with PrimeXM, OneZero, dxTrade and B2Trader, making a total of 6 trading platforms. B2Broker can now offer its customers the opportunity to target a wider range of end-customers across the globe.
Ticket System
B2Core, currently integrated with SupportPal, can now enable clients to offer a ticket-based customer support service within B2Core as a module. Rather than conducting support via Skype and other social networks where information is likely to get lost, using the Ticket System ensures everything is recorded and processed as part of the same procedure.
Detailed MT Analytics
B2Core’s main trading platform integration with MT 4 & 5 allows the end-users to monitor all activities occurring on the MT account directly from their Trader’s Room account. This allows the user to check his requirement and actions with one solution as illustrated:
Withdrawal Address Whitelist
A new whitelist function has been added which is essentially an address whitelist for withdrawal purposes. This is an additional security measure for end users, where they are able to specify their chosen, trusted wallets for withdrawal which means that only these wallets will be logged out of the system. The new security measure has been developed in conjunction with 2FA Google Authenticator.
A Multi-Featured Package To Suit Every Business Need
All in all, B2Core offers a huge range of vital new adjustable features, providing users with the means to pick and choose what suits them. It is the must-have solution for every company and one which is capable of handling client-facing operations of every type of financial business, regardless of complexity. Not only is B2Core highly-customisable, it is an efficient, high-performance system that overrides all the one-size-fits-all client cabinet solutions in the market, and most importantly, one which your users will thank you for choosing.
About B2Broker
B2Broker is a liquidity and technology provider of solutions for the crypto and foreign exchange (FX) industry. The company specialises in the sphere of B2B services and products, catering for a wide range of clients including large licensed brokers, crypto exchanges, crypto brokers, forex brokers, hedge and crypto funds and professional managers.
B2Broker’s advanced base of ready to use technical solutions enable brokers to save time and money on consuming infrastructure projects and focus on enlarging their client base and increasing their revenues.
Please contact B2Broker to enhance your company with B2Core.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200217005010/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 15:13:00 CET | Press release
If approved, BRUKINSA plus rituximab would be the first and only chemotherapy-free, BTK inhibitor-based regimen for adult patients with previously untreated mantle cell lymphomaApplication supported by Phase 3 MANGROVE data, showing a 43% reduction in the risk of progression or death versus bendamustine plus rituximabFull MANGROVE results to be presented during the Plenary Scientific Session at the 68th American Society of Hematology Annual Meeting BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of dis
Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 15:00:00 CET | Press release
This framework agreement provides all entities subject to the French Public Procurement Code with simplified access to a support alternative enabling them to control their costs, preserve their freedom of technological choice and free themselves from vendor-imposed upgrade cycles Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMw
Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 15:00:00 CET | Press release
New data in myeloproliferative neoplasms (MPNs) will include INCA033989, Incyte’s first-in-class, mutant calreticulin (mutCALR)-targeted monoclonal antibody, in first-line myelofibrosis (MF); and preclinical findings for Incyte’s next-generation mutCALR- and JAK2V617F-targeted compoundsUpdated results for INCA033989 in second-line MF and second-line essential thrombocythemia (ET) will build on previously presented datasetsLong-term Phase 1/2 data further characterize the potential of latarcibart (VGA039), an investigational Protein S-targeting antibody, as prophylaxis in adolescents and adults with von Willebrand disease (VWD)More than 30 abstracts will highlight progress across Incyte’s broader hematology portfolioIncyte will host an investor event and webcast on Saturday, December 12, 2026 from 7:30 – 9:00 p.m. CT (8:30 – 10:00 p.m. ET) Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstra
Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 15:00:00 CET | Press release
Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e
Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer4.11.2026 14:41:00 CET | Press release
Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than 20 years of leadership experience in the life sciences industry as Chief Executive Officer of Vivasure Medical and previously from over 15 years in senior leadership roles at Abbott. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104178009/en/ Andrew Glass, CEO, TTxD Following the previously announced changes to the Company’s Board earlier this year, Mr. Glass joins the Company as it transitions from preclinical stage to being a clinical-stage organisation. His expertise in developmental strategy, financing and organisational growth is focussed on expediting the delivery of the aims associated with TTxD’s proprietary
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
